Galanin and glypican-4 are likely to be main regulators in glucose and lipid metabolism and might be associated with insulin resistance and obesity, and PCOS is related with insulin resistance and other metabolic disorders such as dyslipidaemia, hypertension, endothelial dysfunction with reduced vascular compliance and, consequently atherosclerosis. Here, GPC4 is linked to obesity disorder.